NeuroMetrix, Inc. (the “Company”) (Nasdaq: NURO), a medical device company focused on the treatment and management of the neurological complications of diabetes, today said it plans to issue its 2013 full year and fourth quarter financial results before the opening of the market on February 13, 2014. The Company will host a conference call at 8:00 a.m., Eastern Time on February 13, 2014 to discuss its financial results as well as business developments affecting the Company.
Help employers find you! Check out all the jobs and post your resume.
